SLA and intrahepatic cholangiocarcinoma: Previous research has shown that overexpression of SLA inhibits intrahepatic cholangiocarcinoma (IHCC) cell growth and induces cell cycle arrest, suggesting a tumor-suppressive role for SLA in IHCC progression38.